Mutations in PD cluster within the two catalytic domains and ectopic expression of the hyperactive, pathogenic LRRK2-G2019S mutant induces cell death6–9, suggesting that aberrantly increased kinase activity is associated with neurotoxicity and the progression of PD. The gene discussed is LRRK2; the disease is Parkinson disease.